The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 26 2020 for K.Nithyananda Reddy
26-Mar-2020
Download PDF
Aurobindo Pharma
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 26 2020 for K.Nithyananda Reddy